1. Home
  2. CWT vs ARQT Comparison

CWT vs ARQT Comparison

Compare CWT & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo California Water Service Group

CWT

California Water Service Group

HOLD

Current Price

$47.93

Market Cap

3.1B

Sector

Utilities

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$31.43

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWT
ARQT
Founded
1926
2016
Country
United States
United States
Employees
1105
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.2B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
CWT
ARQT
Price
$47.93
$31.43
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
★ $53.75
$38.38
AVG Volume (30 Days)
358.3K
★ 2.2M
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 2.82%
N/A
EPS Growth
N/A
★ 88.79
EPS
★ 1.01
0.03
Revenue
★ $963,695,000.00
$376,072,000.00
Revenue This Year
$9.24
$43.01
Revenue Next Year
$6.80
$27.70
P/E Ratio
★ $47.10
$1,071.67
Revenue Growth
6.41
★ 91.34
52 Week Low
$41.29
$19.30
52 Week High
$53.82
$33.30

Technical Indicators

Market Signals
Indicator
CWT
ARQT
Relative Strength Index (RSI) 59.64 65.74
Support Level $42.84 $23.42
Resistance Level $48.10 N/A
Average True Range (ATR) 1.17 1.58
MACD 0.34 0.61
Stochastic Oscillator 90.35 80.56

Price Performance

Historical Comparison
CWT
ARQT

About CWT California Water Service Group

California Water Service Group is a U.S. water and utilities holding company based in California. The company provides water utility and other related services in California, Washington, New Mexico, Hawaii and Texas through its wholly-owned subsidiaries. The bulk of the company's business consists of the production, purchase, storage, treatment, testing, distribution, and sale of water for domestic, industrial, public, and irrigation uses, and the provision of water for domestic and municipal fire protection services.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: